Korean sleep tech startup Risole is launching a dual-market expansion into the US and Japan using its proprietary brainwave entrainment wearables and AI app ecosystem. With the global sleep tech market projected to hit $49.3B by 2030, Risole’s strategy of combining D2C crowdfunding in the US with B2B healthcare partnerships in Japan offers a masterclass for hardware founders scaling globally. Founders must leverage localized Go-to-Market strategies and ecosystem integration to compete against giants like Oura and Whoop.
The $49B Sleep Tech Opportunity
The global sleep tech market is experiencing explosive growth, driven by an aging population and rising stress levels. Valued at $18.5 billion in 2023, the market is projected to grow at a CAGR of 14.5% to reach $49.3 billion by 2030. While established players like Oura (valued at $800M) and Whoop ($3.6B) dominate the passive tracking space, a new wave of neurotech startups is emerging. Korean startup Risole is capitalizing on this shift, utilizing patented non-invasive brainwave entrainment technology that actively induces deep sleep rather than merely monitoring it.
Ecosystem Over Hardware: The App-First Moat
Hardware alone is a tough business with shrinking margins. Risole’s competitive advantage lies in its ecosystem approach. By pairing its wearable devices (Sleepisol and Blissol) with the ‘Sleepisol BIO’ app—which boasts over 1.9 million downloads and was named a 2025 Google Play Global Best App—the company transforms a one-time hardware purchase into a continuous data loop. For founders in the IoT or wearable space, building a robust software ecosystem is non-negotiable. It not only provides personalized AI analytics to the user but also creates a significant moat against hardware commoditization.
Localized GTM: D2C in the US, B2B in Japan
Risole’s global expansion strategy is a textbook example of localized Go-to-Market (GTM) execution. In the US, where consumer spending on wellness is high, Risole adopted a Direct-to-Consumer (D2C) approach. They validated market demand and raised over $70,000 via Kickstarter, subsequently setting up a Shopify storefront. Conversely, in Japan, a market characterized by a rapidly aging population and strong corporate emphasis on ‘health management’ (kenko keiei), Risole pivoted to a B2B strategy. They partnered with local consulting firms like Funai Research Institute and CROs (Contract Research Organizations) like CMIC to navigate complex medical device certifications and target corporate wellness programs. This dual-track strategy mitigates risk and optimizes resource allocation.
Building Trust and Navigating Regulations
In the health tech sector, regulatory hurdles (like FDA in the US or PMDA in Japan) are the biggest barriers to entry. Risole strategically built credibility by becoming an official member of the US Sleep Foundation. In Japan, their partnership with CMIC accelerates the clinical trial and certification process. Founders must realize that in health tech, trust is your currency. Securing patents early and aligning with recognized institutions are critical steps before attempting to scale globally.
Actionable Insights for Founders
- Validate via Crowdfunding: Use platforms like Kickstarter to test global demand, secure early capital, and refine your messaging before a full-scale D2C launch.
- Build a Data Ecosystem: Don’t just sell hardware. Develop an app ecosystem (like Risole’s 1.9M download app) to collect bio-data, personalize the user experience, and create a recurring engagement loop.
- Tailor Your GTM by Region: Avoid a one-size-fits-all approach. Use D2C channels for consumer-heavy markets like the US, and focus on B2B partnerships and corporate wellness in markets like Japan.
- Partner for Compliance: Do not navigate foreign medical regulations alone. Partner with local CROs and industry associations to fast-track certifications and build immediate brand trust.